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Short Notes
Infections by malaria parasite and human immunodefi-
ciency virus (HIV) represent major public health
problems in many parts of the world. Both infections
kill millions of people each year and both infections
are scourges of developing nations in Africa, India,
southeast Asia and South America1. In recent years, it
has been hypothesised that a possible deleterious in-
teraction between both infections exists. The pre-
sented hypothesis suggested that chronic latent malaria
infection prepares the niche where otherwise feeble
HIV infection can thrive and cause acquired immuno-
deficiency syndrome (AIDS)2. However, an earlier
critical review from numerous available reports on this
subject showed that there were hardly evidences to
support this hypothesis3. Depending on the perspec-
tive it is viewed, malaria has either a lot or very little in
common with HIV. With shared geography and de-
mographics especially in sub-Saharan Africa, co-in-
fection is common, yet surprisingly few obvious clini-
cal associations between HIV and malaria are re-
ported in this region1.
Till date there is a dearth of information on the preva-
lence of malaria and HIV co-infection in Nigeria. The
life expectancy in Nigeria was estimated to have
dropped from 53 years in 1990 to 51 years in 2002,
largely due to the AIDS epidemic. The epidemic in
Nigeria has extended beyond the commonly classified
high-risk groups and is now common in the general
population with the adult prevalence rate at 5.8% in
20014. Our objective in this study was to determine
the prevalence of malaria infection in HIV-seronega-
tive individuals as part of the preliminary investigation
leading to a more advanced research on malaria and
HIV co-infection in Nigeria.
The study was conducted from April 2002 through
November 2003 in Jos-Plateau located in an area
covering about 9,400 km2 of the crystalline complex
in Central Nigeria. The area has two seasons, the dry
season (November–March) and the rainy season
(April–October). Malaria transmission is usually high
towards the end of the rainy season. The Central Ni-
geria is known to record the highest prevalence of
HIV infection in the country4.
Patients who visited Jos University Teaching Hospital
(JUTH) and the Plateau Specialist Hospital (PSH),
who presented themselves for retroviral screening,
were enrolled in the study. Informed consent was ob-
tained from each patient with the assistance of their
physicians. Thereafter, 5 ml of blood sample was ob-J  VECT  BORNE  DIS  42,  DECEMBER  2005 152
tained by vene puncture from each of these patients
for HIV and malaria parasite screening to identify the
appropriate study group. The HIV serostatus of 490
of them (age range 17–60 yr) was confirmed by
immunoblot analysis (Bio-Rad, Novapath Diagnostic
Group, U.S.A.) at the International Centre for Scien-
tific Culture (ICSC) Retroviral Laboratory, PSH, Jos.
This was after an initial HIV screening using the
Vironostica® HIV-1 microelisa system (Organon
Teknika, Durham, U.S.A.) at the AIDS/Leishmaniasis
Research Laboratory, University of Jos. These 490
individuals constituted the HIV-seropositive popula-
tion. Thick and thin blood films were made 2–3 h of
collection, stained with Giemsa according to standard
protocol for the identification of malaria parasite5.
The HIV-seronegative population comprised of 578
individuals (10–59 yr age) who were HIV-seronega-
tive by the Vironostica® HIV-1 microelisa system and
were participants of the community targeted voluntary
counseling test (VCT) for HIV-infection conducted in
various areas of Jos-Plateau. These individuals willing-
ly offered to be screened for HIV during these pro-
grammes. All the study participants were informed
verbally and their consent duly obtained. Thick and
thin blood films for malaria parasite diagnosis were
performed as described earlier5, after the HIV-se-
rostatus was established for each individual. Differ-
ences between proportions were evaluated by the chi-
square test. Statistical significance was achieved if p <
0.05.
Of the 490 HIV-seropositive individuals studied 103
(21%, 95% CI 17.41–24.63) had malaria infection,
while 67 (11.6%, 95% CI 8.98–14.2) of the 578
HIV-seronegative individuals also had malaria infec-
tion. Plasmodium falciparum was identified in all the
cases.  Mixed infections of P. falciparum and  P. ma-
lariae occurred in 2.6% of all the infected cases.
Amongst the HIV-seropositive individuals, the males
were significantly more infected than the females
(27.4%, 95% CI 21.2–33.52 vs 16.6%, 95% CI
12.32–20.9);  (c2 = 8.198, p < 0.05, df =1 ) (Table 1)
The prevalence of malaria infection increased with age
amongst the HIV-seropositive individuals with the
highest rate of 32% (95% CI 13.71–50.29) at the 51–
60 yr age group, although there exist no significant dif-
ference in the trend (c2 =5.697, p < 0.05, df = 4). The
prevalence of malaria infection was slightly higher
amongst the males (12.7%, 95% CI 8.76–16.58) than
the females (10.4%, 95% CI 6.84 –14.02) in the HIV-
seronegative population (Table 1). There was no signifi-
cant difference statistically (c2 = 0.693, p < 0.05, df  =
1). Amongst the HIV-seronegative individuals, the high-
est prevalence of malaria infection of 14.8% (95% CI
8.68–21) was observed at the 31–40 yr age category
(Table 1). There was also no sigificant difference statis-
tically (c2=4.987, p < 0.05, df = 4).
Table 1. Malaria infection amongst HIV-seropositive and
seronegative individuals in Jos-Nigeria
Parameter No. No. with 95%
 examined malaria confidence
infection interval
HIV-seropositive
Sex
Male 201 55 (27.4) 21.2–33.52
Female 289 48 (16.6) 12.32–20.9
Total 490 103 (21) 17.41–24.63
Age (yr)
< 20 15 2 (13.3) 3.87–30.53
21–30 184 27 (14.7) 9.56–19.78
31–40 188 44 (23.4) 17.35–29.45
41–50 78 21 (26.9) 17.08–36.76
51–60 25  8 (32) 13.71–50.29
Total 490 103 (21) 17.41–24.63
HIV-seronegative
Sex
Male 300 38 (12.7) 8.76–16.58
Female 278 29 (10.4) 6.84–14.02
Total 578 67 (11.6) 8.98–14.2
Age (yr)
< 20 215 20 (9.3) 5.42–13.18
21–30 195 26 (13.3) 8.56–18.1
31–40 128 19 (14.8) 8.68–21
41–50 35 2 (5.7) 1.98–13.4
51–60 5  0 (0) –
Total 578 67 (11.6) 8.98–14.2
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This investigation demonstrated that HIV-seropositive
individuals had a higher prevalence of malaria infection
than the HIV-seronegative individuals in the study
area. Jos-Plateau is considered as an area of stable P.
falciparum malaria transmission although consider-
able urbanisation processes are going on. Neverthe-
less, the inhabitants have developed a high degree of
immunity to the parasite through repeated exposures,
and thus are not generally susceptible to the effects of
severe clinical malaria. This may have accounted for
the lower prevalence of malaria infection amongst the
HIV-seronegative population.
The humoral and cell-mediated immunity to malaria
parasite are reported to be developed in such an area
of stable transmission6. This immunity can be altered
in HIV-infected persons and could influence the fre-
quency and course of malaria infection7, 8. This may
explain the higher prevalence of malaria infection in the
HIV-seropositive population. This submission may not
be conclusive as HIV-disease progression co-factors
such as : presence of opportunistic infections, nutri-
tional status, age, viral load and genotype9, could also
have influenced the malaria infection in the HIV-in-
fected population. Our inability to record the parasite
density is a major drawback to this research. Future
studies integrating the parasite density are advocated.
Present result showed that males were more infected
with the malaria parasite than the females in both of
the study population. This was not unexpected be-
cause analysis of sociobehavioural factors revealed
that males expose themselves more to the risk factors
of malaria acquisition. It is a common habit of males in
Jos-Plateau to stay long hours into the night outside
the houses or sleep outdoors without appropriate
coverings. There is also high level of indifference to
the use of insecticide-treated bednets by the males.
Malaria infection prevalence increased with age
amongst the HIV-seropositive individuals, although a
somewhat similar pattern was observed amongst the
HIV-seronegative population but it was less obvious
in the latter. A review of a number of studies in differ-
ent transmission groups confirmed that age is a co-
factor for disease progression9. The immunity to ma-
laria and HIV-1 infection has been shown to be age
dependent10. It is possible that the older HIV-infected
individuals may be more likely to develop infections
including malaria than the younger HIV-infected
individuals.
In conclusion it is imperative to state that people who
have grown up in malaria endemic regions especially
in the sub-Saharan Africa often retain partial immunity
to malaria, and there is no solid evidence that this im-
munity is lost, as HIV disease progresses1. However,
it is suggested that the roots of the HIV outbreak and
AIDS pandemic lay in the urbanisation processes in
many developing countries of the sub-Saharan Africa
including Nigeria, which have resulted in the eradica-
tion of the Anopheles vector from previously endemic
areas, with consequent loss of natural immunity
thereby enhancing vulnerability to opportunistic infec-
tions, HIV among them2. Our findings have provided
additional baseline information on the burden of ma-
laria and HIV coinfection in Nigeria. Further research
is advocated on this subject especially in the sub-Sa-
haran Africa, the region with the highest prevalence of
both infections.
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